4-Methoxyisoindolin-1-one

Catalog No.: 
ACRFJE604
CAS No.: 
366453-22-7
Molecular Formula: 
C9H9NO2
Molecular Weight: 
163.18
4-Methoxyisoindolin-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$125.00In stockIn stock
10g95%$248.00In stockIn stock
25g95%$602.00In stockInquiry
100g95%$1949.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methoxyisoindolin-1-one
IUPAC Name4-methoxyisoindolin-1-one
MDL No.MFCD09701287
Molecular FormulaC9H9NO2
Molecular Weight163.18
SMILESO=C1NCC2=C1C=CC=C2OC
InChI KeyONNGVKRXGAJQKC-UHFFFAOYSA-N
Synonym4-Methoxyisoindolin-1-one | 366453-22-7 | 4-methoxy-2,3-dihydroisoindol-1-one | 4-methoxy-2,3-dihydro-1H-isoindol-1-one | 4-METHOXY-2,3-DIHYDRO-ISOINDOL-1-ONE | 1H-Isoindol-1-one,2,3-dihydro-4-methoxy-(9CI) | MFCD09701287 | 2,3-Dihydro-4-methoxy-1H-isoindol-1-one | SCHEM
CAS No.366453-22-7
PubChem CID11672718

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRFJE604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIWJO943 route compound structure diagram
    ACIWJO943366453-21-6In Stock
  4. Then
  5. ACRFJE604 route product structure diagram
    ACRFJE604366453-22-7In Stock
Inquiry

2. ACRFJE604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRFJE604 route product structure diagram
    ACRFJE604366453-22-7In Stock
Inquiry

3. ACRFJE604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRFJE604 route product structure diagram
    ACRFJE604366453-22-7In Stock
Inquiry

Comments (0)